Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative tranexamic acid in melanoma surgery
2022-502633-26-00Phase 3Authorised
- Sponsor
- Aarhus University Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cutaneous melanoma (CM) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Histopathological confirmed relapse. Planned start Mar 2023; status: authorised.
02
Drugs
tranexamic acid
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on 2022-502633-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502633-26-00.